Prucalopride NDC 62332-077

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-077Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0077Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-077-30	62332007730	30 TABLET, FILM COATED in 1 BOTTLE (62332-077-30)Marketed from Jul 31, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prucalopride
Generic name (nonproprietary): prucalopride
Active ingredients: Prucalopride succinate — 1 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219234
Marketing start: Jul 31, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 4 Receptor Agonists (Mechanism)
Identifiers: Product ID 62332-077_b1c03c28-cd41-4ef2-a79e-f1912cb75d9dSPL ID b1c03c28-cd41-4ef2-a79e-f1912cb75d9dSPL set ID a537fb70-eb4e-4498-aaef-9944ff390009RxCUI 2107345, 2107353UNII 4V2G75E1CKUPC 0362332077304, 0362332078301
Pharmacologic class: Serotonin-4 Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332007730 followed by a unit qualifier and the quantity

Package 62332-0077-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 31, 2026.

Indications (excerpt from the label)

Prucalopride tablet is indicated for the treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride tablet is a serotonin-4 (5-HT 4 ) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219234

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219234
Product	Strength	Form · route	Labeler	Product NDC
Prucalopride	Prucalopride succinate 1 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-077
Prucalopride	Prucalopride succinate 2 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-078
Prucalopride	Prucalopride succinate 2 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-078